Institute for OneWorld Health awarded Skoll Foundation's Social Entrepreneurship Award

San Francisco, Calif. March 21, 2005 The Institute for OneWorld Health today announced that it has been awarded a 2005 Skoll Award for Social Entrepreneurship in the amount of $615,000 over three years. Based in San Francisco, OneWorld Health is the first nonprofit pharmaceutical company in the U.S. and develops new medicines to cure infectious diseases that disproportionately affect the poorest people in the world.

OneWorld Health is one of 13 organizations receiving $7.3 million from the Skoll Foundation through an open competitive process that identifies social entrepreneurs who have piloted innovative programs and are ready to take the next steps toward systemic social change. The awards will be presented on March 31 at the second annual Skoll World Forum on Social Entrepreneurship at Oxford University in England, where some of the world's leading practitioners and thought leaders in social entrepreneurship will convene to set the future agenda for visionaries who want to transform society.

"OneWorld Health is honored to be among this year's Skoll Award recipients," said Dr. Victoria Hale, founder and CEO of the Institute for OneWorld Health. "The Skoll Foundation recognizes the challenges each of our organizations face, and is leading the philanthropic community in its commitment to social innovators."

The Skoll Foundation's mission is to advance systemic change benefiting communities around the world by investing in, connecting and celebrating social entrepreneurs, who are individuals dedicated to creating new solutions that result in lasting improvements to complex social problems.

"We have cast our net far and wide to find the world's best social entrepreneurs," said Sally Osberg, President and CEO of the Skoll Foundation. "OneWorld Health is tackling a complex social problem in order to promote healthy, sustainable communities."


Contact: Joanne Hasegawa
Institute for OneWorld Health

Page: 1

Related biology news :

1. Weizmann Institute scientists discover a control mechanism for metastasis
2. UCLAs California NanoSystems Institute partners with Abraxis BioScience
3. Wiley extends publishing partnership with the American Institute of Chemical Engineers
4. Biodesign Institute leads innovative project to prevent cancer
5. DOE Joint Genome Institute secures long-term lease on production genomics facility
6. Weizmann Institute scientists develop a general control switch for protein activity
7. Research without borders: Head of Santa Fe Institute to address NSF
8. Stowers Institutes Workman Lab demonstrates mechanism for decoding histone modification marks
9. The Institute of Ecosystem Studies recognized by the Wildlife Society
10. 2007 Wistar Institute Science Journalism Award winner announced
11. UCLA AIDS Institute researchers find a peptide that encourages HIV infection

Post Your Comments:

(Date:7/1/2020)... ... 2020 , ... Catalent, a global leader in clinical supply ... facility in Minakuchi, located in the Shiga prefecture of Japan. , Operating in ... new 60,000-square-foot facility will provide customers with flexible clinical supply solutions, serving both ...
(Date:6/28/2020)... Switzerland (PRWEB) , ... June ... ... provider of enterprise software solutions for biopharmaceutical R&D, today announced that it ... company developing innovative, full-length multispecific antibodies (Multiclonics®), to support their translational and ...
(Date:6/25/2020)... ... June 24, 2020 , ... ... software-driven clinical data services that accelerate drug development, is collaborating with Karyopharm Therapeutics ... inhibitor, in hospitalized patients with severe COVID-19. This is the first study of ...
Breaking Biology News(10 mins):
(Date:7/10/2020)... ... July 08, 2020 , ... Bode Technology, a ... laboratory operations through its COVID-19 testing service, Bode-CARES . Bode-CARES combines high-volume ... Bode-CARES provides a turnkey solution that includes a comprehensive collection and virus-management ...
(Date:7/10/2020)... ... July 09, 2020 , ... In most research using the ... pigment formation in zebrafish embryos, maintaining optical transparency to facilitate microscopic imaging. Over ... been using the zebrafish model to investigate the causes of leukaemia and its ...
(Date:7/7/2020)... ... July 06, 2020 , ... R3 International is now offering ... to 200 million stem cells. Depending on the patient's condition, treatment may be offered ... will die having some form of Alzheimers dementia, and the incidence continues to increase ...
(Date:7/1/2020)... ... June 29, 2020 , ... MedShift , a ... 2020, despite many obstacles created as a result of COVID-19. As a provider ... partnered medical practices and medical manufacturers by expanding access to device offerings, technology ...
Breaking Biology Technology:
Cached News: